AAAAAA

   
Results: 1-25 | 26-50 | 51-53
Results: 1-25/53
GENDER-RELATED DIFFERENCES IN THE RELATIONSHIP BETWEEN DENSITOMETRIC VALUES OF WHOLE-BODY BONE-MINERAL CONTENT AND LEAN BODY-MASS IN HUMANSBETWEEN 2 AND 87 YEARS OF AGE
Authors: FERRETTI JL CAPOZZA RF COINTRY GR GARCIA SL PLOTKIN H FILGUEIRA MLA ZANCHETTA JR
Citation: Jl. Ferretti et al., GENDER-RELATED DIFFERENCES IN THE RELATIONSHIP BETWEEN DENSITOMETRIC VALUES OF WHOLE-BODY BONE-MINERAL CONTENT AND LEAN BODY-MASS IN HUMANSBETWEEN 2 AND 87 YEARS OF AGE, Bone, 22(6), 1998, pp. 683-690
EFFECT OF ANTIRESORPTIVE THERAPY ON DAY-TO-DAY VARIATION OF URINARY FREE DEOXYPYRIDINOLINE EXCRETION
Authors: FRADINGER EE RODRIGUEZ G BOGADO C ZANCHETTA JR
Citation: Ee. Fradinger et al., EFFECT OF ANTIRESORPTIVE THERAPY ON DAY-TO-DAY VARIATION OF URINARY FREE DEOXYPYRIDINOLINE EXCRETION, Clinical chemistry, 44(10), 1998, pp. 2224-2225
COMPARATIVE EFFECT OF DAIRY AND NONDAIRY PRODUCTS DECREASING SERUM PTH IN HEALTHY-VOLUNTEERS
Authors: TALBOT JR GUARDO P SECCIA S GEAR L RODRIGUEZLUBARY D SAAD G ROBERTS ML FRADINGER E MARINO A ZANCHETTA JR
Citation: Jr. Talbot et al., COMPARATIVE EFFECT OF DAIRY AND NONDAIRY PRODUCTS DECREASING SERUM PTH IN HEALTHY-VOLUNTEERS, Journal of bone and mineral research, 12, 1997, pp. 388-388
INSULIN-LIKE-GROWTH-FACTOR BINDING PROTEIN-3 LEVELS IN SERA FROM HEALTHY AND OSTEOPOROTIC WOMEN
Authors: PLOTKIN LI MATHOV I SARLI M ZANCHETTA JR PLOTKIN H LEONI J
Citation: Li. Plotkin et al., INSULIN-LIKE-GROWTH-FACTOR BINDING PROTEIN-3 LEVELS IN SERA FROM HEALTHY AND OSTEOPOROTIC WOMEN, Journal of bone and mineral research, 12, 1997, pp. 452-452
INCIDENCE OF ADVERSE-EFFECTS IN OSTEOPOROTIC PATIENTS TREATED WITH ALENDRONATE
Authors: ZANCHETTA JR SPIVACOW R REY P MORILLO S INSUA A RODRIGUEZ G NEGRI A DELVALLE E MASSARI F SARLI M TALBOT JR
Citation: Jr. Zanchetta et al., INCIDENCE OF ADVERSE-EFFECTS IN OSTEOPOROTIC PATIENTS TREATED WITH ALENDRONATE, Journal of bone and mineral research, 12, 1997, pp. 465-465
IPTH LEVELS IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS TREATED WITH ALENDRONATE
Authors: MASSARI F ZANCHETTA JR
Citation: F. Massari et Jr. Zanchetta, IPTH LEVELS IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS TREATED WITH ALENDRONATE, Journal of bone and mineral research, 12, 1997, pp. 470-470
TREATMENT OF THE REFLEX SYMPATHETIC DYSTROPHY SYNDROME WITH IV PAMIDRONATE
Authors: MORILLO S REY P SARLI M ZANCHETTA JR
Citation: S. Morillo et al., TREATMENT OF THE REFLEX SYMPATHETIC DYSTROPHY SYNDROME WITH IV PAMIDRONATE, Journal of bone and mineral research, 12, 1997, pp. 528-528
PERFORMANCE OF URINARY MARKERS OF BONE-RESORPTION EXPRESSED AS T-SCORE
Authors: FRADINGER EE VOLTA SM SALICA D ZANCHETTA JR BOGADO CE
Citation: Ee. Fradinger et al., PERFORMANCE OF URINARY MARKERS OF BONE-RESORPTION EXPRESSED AS T-SCORE, Journal of bone and mineral research, 12, 1997, pp. 588-588
INCREASED BONE-RESORPTION IS ASSOCIATED WITH HYPERCALCIURIC RECURRENTKIDNEY-STONE DISEASE IN MALES
Authors: DELVALLE E MARINO A SPIVACOW R TALBOT JR ZANCHETTA JR
Citation: E. Delvalle et al., INCREASED BONE-RESORPTION IS ASSOCIATED WITH HYPERCALCIURIC RECURRENTKIDNEY-STONE DISEASE IN MALES, Journal of bone and mineral research, 12, 1997, pp. 695-695
ASSOCIATION BETWEEN PAGETS-DISEASE AND PR IMARY HYPERPARATHYROIDISM
Authors: SARLI MA SPIVACOW R MORILLO S ZANCHETTA JR
Citation: Ma. Sarli et al., ASSOCIATION BETWEEN PAGETS-DISEASE AND PR IMARY HYPERPARATHYROIDISM, Medicina, 57(6), 1997, pp. 685-692
EXPERIMENTAL EFFECTS OF OLPADRONATE AND PAMIDRONATE ON BONE MASS
Authors: MONDELO N PARMA MD PELUFFO VA ZANCHETTA JR PICCINNI E MONTUORI E
Citation: N. Mondelo et al., EXPERIMENTAL EFFECTS OF OLPADRONATE AND PAMIDRONATE ON BONE MASS, Medicina, 57, 1997, pp. 17-24
PROTRACTED USE, UP TO 6 YEARS, OF AN ORALAMINOBISPHOSPHONATE IN PATIENTS WITH ESTABLISHED OSTEOPOROSIS
Authors: ZANCHETTA JR SPIVACOW RF BOGADO C SARLI M PLOTKIN H ROLDAN EJA
Citation: Jr. Zanchetta et al., PROTRACTED USE, UP TO 6 YEARS, OF AN ORALAMINOBISPHOSPHONATE IN PATIENTS WITH ESTABLISHED OSTEOPOROSIS, Medicina, 57, 1997, pp. 37-44
TOLERABILITY OF ORAL BISPHOSPHONATES IN PATIENTS WITH OSTEOPOROSIS AND OTHER OSTEOPATHIES
Authors: SPIVACOW R ROLDAN EJA ZANETTI D PICCINNI E ZANCHETTA JR
Citation: R. Spivacow et al., TOLERABILITY OF ORAL BISPHOSPHONATES IN PATIENTS WITH OSTEOPOROSIS AND OTHER OSTEOPATHIES, Medicina, 57, 1997, pp. 114-118
MECHANICAL VALIDATION OF A TOMOGRAPHIC (PQCT) INDEX FOR NONINVASIVE ESTIMATION OF RAT FEMUR BENDING STRENGTH
Authors: FERRETTI JL CAPOZZA RF ZANCHETTA JR
Citation: Jl. Ferretti et al., MECHANICAL VALIDATION OF A TOMOGRAPHIC (PQCT) INDEX FOR NONINVASIVE ESTIMATION OF RAT FEMUR BENDING STRENGTH, Bone, 18(2), 1996, pp. 97-102
WEEKLY TRANSDERMAL 17-BETA ESTRADIOL PATCH WERE EFFECTIVE TO DECREASEBONE-RESORPTION IN POSTMENOPAUSAL HEALTHY WOMEN
Authors: MARTINEZ GM TALBOT JR VIZZON L FRADINGER E PEREDA C ZANCHETTA JR
Citation: Gm. Martinez et al., WEEKLY TRANSDERMAL 17-BETA ESTRADIOL PATCH WERE EFFECTIVE TO DECREASEBONE-RESORPTION IN POSTMENOPAUSAL HEALTHY WOMEN, Journal of bone and mineral research, 11, 1996, pp. 606-606
FEMUR MASS, ARCHITECTURE, AND MINERALIZATION AS AFFECTED BY HIGH-DOSES OF OLPADRONATE IN MICE - A TOMOGRAPHIC (PQCT) STUDY
Authors: COINTRY GR MONDELO N PELUFFO V MONTUORI E ZANCHETTA JR FERRETTI JL
Citation: Gr. Cointry et al., FEMUR MASS, ARCHITECTURE, AND MINERALIZATION AS AFFECTED BY HIGH-DOSES OF OLPADRONATE IN MICE - A TOMOGRAPHIC (PQCT) STUDY, Journal of bone and mineral research, 11, 1996, pp. 621-621
EFFECT OF ORAL PAMIDRONATE TREATMENT ON BONE-MINERAL CONTENT IN POSTMENOPAUSAL OSTEOPOROTIC WOMEN WITH HIGH OR NORMAL BIOCHEMICAL INDEXES OF BONE-RESORPTION
Authors: BOGADO CE ZANCHETTA JR
Citation: Ce. Bogado et Jr. Zanchetta, EFFECT OF ORAL PAMIDRONATE TREATMENT ON BONE-MINERAL CONTENT IN POSTMENOPAUSAL OSTEOPOROTIC WOMEN WITH HIGH OR NORMAL BIOCHEMICAL INDEXES OF BONE-RESORPTION, Journal of bone and mineral research, 11, 1996, pp. 657-657
HYPERCALCIURIA DECREASES SPINE AND IIIP BONE MASS IN MALE-PATIENTS WITH RECURRENT KIDNEY-STONE DISEASE
Authors: SPIVACOW R MARINO A DELVALLE E TALBOT JR ZANCHETTA JR
Citation: R. Spivacow et al., HYPERCALCIURIA DECREASES SPINE AND IIIP BONE MASS IN MALE-PATIENTS WITH RECURRENT KIDNEY-STONE DISEASE, Journal of bone and mineral research, 11, 1996, pp. 772-772
MINERAL DENSITY GAIN IN VERTEBRAE OF OSTEOPOROTIC WOMEN ON ORAL PAMIDRONATE REVERTS A YEAR AFTER TREATMENT DISCONTINUANCE
Authors: ZANCHETTA JR PLOTKIN H ROLDAN EJA
Citation: Jr. Zanchetta et al., MINERAL DENSITY GAIN IN VERTEBRAE OF OSTEOPOROTIC WOMEN ON ORAL PAMIDRONATE REVERTS A YEAR AFTER TREATMENT DISCONTINUANCE, Calcified tissue international, 59(1), 1996, pp. 70-72
LUMBAR SPINE BONE-DENSITY IN ARGENTINE CHILDREN
Authors: PLOTKIN H NUNEZ M FILGUEIRA MLA ZANCHETTA JR
Citation: H. Plotkin et al., LUMBAR SPINE BONE-DENSITY IN ARGENTINE CHILDREN, Calcified tissue international, 58(3), 1996, pp. 144-149
OSTEOPOROSIS FOLLOWING HEART-TRANSPLANTATION
Authors: NEGRI AL PERRONE S GALLO R BOGADO CE ZANCHETTA JR
Citation: Al. Negri et al., OSTEOPOROSIS FOLLOWING HEART-TRANSPLANTATION, Transplantation proceedings, 28(6), 1996, pp. 3321-3324
BONE-MINERAL DENSITY IN PATIENTS WITH HYPERCALCIURIC NEPHROLITHIASIS
Authors: ZANCHETTA JR RODRIGUEZ G NEGRI AL DELVALLE E SPIVACOW FR
Citation: Jr. Zanchetta et al., BONE-MINERAL DENSITY IN PATIENTS WITH HYPERCALCIURIC NEPHROLITHIASIS, Nephron, 73(4), 1996, pp. 557-560
TOLERABILITY OF ORAL PAMIDRONATE IN ELDERLY PATIENTS WITH OSTEOPOROSIS AND OTHER METABOLIC BONE-DISEASES
Authors: SPIVACOW FR ZANCHETTA JR KERZBERG EM FRIGERI A FIASCHE R ROLDAN EJA
Citation: Fr. Spivacow et al., TOLERABILITY OF ORAL PAMIDRONATE IN ELDERLY PATIENTS WITH OSTEOPOROSIS AND OTHER METABOLIC BONE-DISEASES, Current therapeutic research, 57(2), 1996, pp. 123-130
INTRAVENOUS OLPADRONATE RESTORES OVARIECTOMY-AFFECTED BONE STRENGTH -A MECHANICAL, DENSITOMETRIC AND TOMOGRAPHIC (PQCT) STUDY
Authors: COINTRY GR MONDELO N ZANCHETTA JR MONTUORI E FERRETTI JL
Citation: Gr. Cointry et al., INTRAVENOUS OLPADRONATE RESTORES OVARIECTOMY-AFFECTED BONE STRENGTH -A MECHANICAL, DENSITOMETRIC AND TOMOGRAPHIC (PQCT) STUDY, Bone, 17(4), 1995, pp. 373-378
EFFECTS OF LARGE DOSES OF OLPADRONATE (DIMETHYL-PAMIDRONATE) ON MINERAL DENSITY, CROSS-SECTIONAL ARCHITECTURE, AND MECHANICAL-PROPERTIES OFRAT FEMURS
Authors: FERRETTI JL MONDELO N CAPOZZA RF COINTRY GR ZANCHETTA JR MONTUORI E
Citation: Jl. Ferretti et al., EFFECTS OF LARGE DOSES OF OLPADRONATE (DIMETHYL-PAMIDRONATE) ON MINERAL DENSITY, CROSS-SECTIONAL ARCHITECTURE, AND MECHANICAL-PROPERTIES OFRAT FEMURS, Bone, 16(4), 1995, pp. 285-293
Risultati: 1-25 | 26-50 | 51-53